Variant report
Variant | esv3448012 |
---|---|
Chromosome Location | chr9:9390992-9391562 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569358849 | chr9:9390993-9390994 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530184827 | chr9:9390996-9390997 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548723144 | chr9:9391019-9391020 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10816115 | chr9:9391030-9391031 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs530165576 | chr9:9391033-9391034 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10816116 | chr9:9391051-9391052 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs142463544 | chr9:9391063-9391064 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377213955 | chr9:9391069-9391070 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537620056 | chr9:9391085-9391086 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10816117 | chr9:9391120-9391121 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs147400366 | chr9:9391153-9391154 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374636515 | chr9:9391154-9391155 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77254810 | chr9:9391156-9391157 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531978562 | chr9:9391188-9391189 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187076892 | chr9:9391189-9391190 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191885497 | chr9:9391230-9391231 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549032673 | chr9:9391232-9391233 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568268183 | chr9:9391275-9391276 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571905713 | chr9:9391360-9391361 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10816118 | chr9:9391364-9391365 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs565418754 | chr9:9391373-9391374 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145981038 | chr9:9391389-9391390 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544937712 | chr9:9391418-9391419 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547651527 | chr9:9391424-9391425 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563046121 | chr9:9391474-9391475 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570464390 | chr9:9391484-9391485 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548945257 | chr9:9391509-9391510 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530323003 | chr9:9391534-9391535 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548664681 | chr9:9391545-9391546 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182900613 | chr9:9391562-9391563 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9390800-9391000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:9390800-9391000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr9:9391000-9391400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
4 | chr9:9391000-9391600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr9:9391400-9391800 | Enhancers | Pancreatic Islets | Pancreatic Islet |